NO880022L - Fremstilling av m-csf. - Google Patents
Fremstilling av m-csf.Info
- Publication number
- NO880022L NO880022L NO880022A NO880022A NO880022L NO 880022 L NO880022 L NO 880022L NO 880022 A NO880022 A NO 880022A NO 880022 A NO880022 A NO 880022A NO 880022 L NO880022 L NO 880022L
- Authority
- NO
- Norway
- Prior art keywords
- csf
- preparation
- enclosed
- defects
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Prostheses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/860,377 US4879227A (en) | 1986-05-06 | 1986-05-06 | Production of a recombinant human colony stimulating factor |
US06/940,362 US4868119A (en) | 1986-12-11 | 1986-12-11 | Hematopoietic growth factors |
PCT/US1987/000835 WO1987006954A1 (en) | 1986-05-06 | 1987-04-13 | Production of m-csf |
Publications (2)
Publication Number | Publication Date |
---|---|
NO880022D0 NO880022D0 (no) | 1988-01-05 |
NO880022L true NO880022L (no) | 1988-01-05 |
Family
ID=27127565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO880022A NO880022L (no) | 1986-05-06 | 1988-01-05 | Fremstilling av m-csf. |
Country Status (21)
Country | Link |
---|---|
US (1) | US5573763A (hu) |
EP (1) | EP0307402B1 (hu) |
JP (2) | JP2579981B2 (hu) |
KR (1) | KR960004453B1 (hu) |
AT (1) | ATE92966T1 (hu) |
AU (1) | AU606056B2 (hu) |
CA (1) | CA1334942C (hu) |
DE (1) | DE3787020T2 (hu) |
DK (1) | DK2688A (hu) |
ES (1) | ES2007341A6 (hu) |
FI (1) | FI884877A0 (hu) |
GR (1) | GR870688B (hu) |
HU (1) | HU212277B (hu) |
IE (1) | IE60835B1 (hu) |
IL (1) | IL82400A0 (hu) |
MX (1) | MX9203130A (hu) |
MY (1) | MY101209A (hu) |
NO (1) | NO880022L (hu) |
OA (1) | OA09112A (hu) |
PH (1) | PH24301A (hu) |
WO (1) | WO1987006954A1 (hu) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5573930A (en) * | 1985-02-05 | 1996-11-12 | Cetus Oncology Corporation | DNA encoding various forms of colony stimulating factor-1 |
US5422105A (en) * | 1985-02-05 | 1995-06-06 | Cetus Oncology Corporation | Use of recombinant colony stimulating factor 1 |
US5556620A (en) * | 1985-02-05 | 1996-09-17 | Cetus Oncology Corporation | Use of recombinant colony stimulating factor-1 to enhance wound healing |
US6156300A (en) * | 1985-02-05 | 2000-12-05 | Chiron Corporation | Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof |
US6103224A (en) * | 1985-02-05 | 2000-08-15 | Chiron Corporation | N∇2 CSF-1 (short form) and carboxy truncated fragments thereof |
US5837229A (en) * | 1985-02-05 | 1998-11-17 | Chiron Corporation | Uses of recombinant colony stimulating factor-1 |
WO1986004607A1 (en) * | 1985-02-05 | 1986-08-14 | Cetus Corporation | Recombinant colony stimulating factor-1 |
US4847201A (en) * | 1985-02-05 | 1989-07-11 | Cetus Corporation | DNA encoding for CSF-1 and accompanying recombinant systems |
US5104650A (en) * | 1985-02-05 | 1992-04-14 | Cetus Corporation | Uses of recombinant colony stimulating factor-1 |
US4808611A (en) * | 1986-07-30 | 1989-02-28 | Immunex Corporation | Use of interleukin-1 to induce development of multipotent hemopoietic cell populations |
US5650297A (en) * | 1986-09-17 | 1997-07-22 | Otsuka Pharmaceutical Co., Ltd. | DNA encoding human colony-stimulating factors |
JP2583770B2 (ja) * | 1986-09-17 | 1997-02-19 | 大塚製薬株式会社 | 遺伝子 |
JP2583829B2 (ja) * | 1986-09-17 | 1997-02-19 | 大塚製薬株式会社 | ヒトm−csf |
JPH07100720B2 (ja) * | 1987-07-17 | 1995-11-01 | 森永乳業株式会社 | コロニー刺激因子の製造法 |
CA1339757C (en) * | 1987-04-16 | 1998-03-17 | Robert F. Halenbeck | Production of purified biologically active, bacterially produced recombinant human csf-1 |
IL86090A (en) * | 1987-04-16 | 1993-03-15 | Cetus Oncology Corp | Production of purified, biologically active, bacterially produced recombinant human csf-1 |
US4929700A (en) * | 1987-04-16 | 1990-05-29 | Cetus Corporation | Production of purified, biologically active, bacterially produced recombinant human CSF-1 |
EP0643972B1 (en) * | 1987-09-22 | 2002-03-06 | Chiron Corporation | Use of recombinant colony stimulating factor-1 for the preparation of a medicament for cytomegalovirus infections |
US5260421A (en) * | 1987-12-21 | 1993-11-09 | Applied Research Systems Ars Holding N.V. | Site-directed mutagenesis modified glycoprotein hormones |
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
DK54589A (da) * | 1988-02-08 | 1989-08-09 | Otsuka Pharma Co Ltd | Humane kolonistmulerende faktorer |
JPH0610137B2 (ja) * | 1988-02-29 | 1994-02-09 | 新技術事業団 | ヒト単球−マクロファージコロニー刺激因子を有効成分とする造血器疾患治療剤 |
WO1989010158A1 (en) * | 1988-04-27 | 1989-11-02 | Immunomedics, Inc. | Improved radiotherapy |
US5888495A (en) * | 1988-05-23 | 1999-03-30 | Genetics Institute, Inc. | Method of producing storage stable M-CSF lyophilizates |
US5171675A (en) * | 1988-07-28 | 1992-12-15 | Cerretti Douglas P | Macrophage colony stimulating factor-γ |
WO1990008554A1 (en) * | 1989-01-30 | 1990-08-09 | Schering Corporation | Treatment of leukocyte dysfunction with gm-csf |
ES2091816T3 (es) * | 1989-02-10 | 1996-11-16 | Cetus Oncology Corp | Anticuerpos monoclonales del factor estimulador de colonias de macrofagos (m-csf) que reconocen un epitope conformacional neutralizante. |
CA2011050C (en) * | 1989-02-28 | 2000-08-08 | Fumimaro Takaku | Human monocyte-machrophage-csf preparations |
US5288487A (en) * | 1989-02-28 | 1994-02-22 | Morinaga Milk Industry Co., Ltd. | Human monocyte-macrophage-CSF preparations |
AU5355790A (en) * | 1989-04-19 | 1990-11-16 | Cetus Corporation | Multifunctional m-csf proteins and genes encoding therefor |
EP0410751B1 (en) * | 1989-07-27 | 1996-04-10 | Denki Kagaku Kogyo Kabushiki Kaisha | Gene encoding M-CSF and related recombinant systems thereof |
AU6125294A (en) * | 1993-01-13 | 1994-08-15 | Genetics Institute Inc. | Process for producing m-csf 223 |
DE69738521T2 (de) | 1996-04-05 | 2009-05-07 | Novartis Vaccines and Diagnostics, Inc., Emeryville | Alphaviren-vektors mit einer reduzierten inhibierung der synthese von zellmakromolekülen |
US6455678B1 (en) * | 1996-04-26 | 2002-09-24 | Amcell Corporation | Human hematopoietic stem and progenitor cell antigen |
CA2260014A1 (en) * | 1996-07-10 | 1998-01-15 | Meiji Milk Products Co., Ltd. | Novel use of mk family as hematopoietic factor |
EP2266542A3 (en) * | 1998-10-01 | 2013-07-31 | Elan Pharma International Limited | Controlled release nanoparticulate compositions |
US7108852B2 (en) | 2000-03-20 | 2006-09-19 | Warner-Lambert Company Llc | Methods of treating inflammation using antibodies to M-CSF |
AR045563A1 (es) * | 2003-09-10 | 2005-11-02 | Warner Lambert Co | Anticuerpos dirigidos a m-csf |
WO2008060610A2 (en) * | 2006-11-17 | 2008-05-22 | Biogen Idec Ma Inc. | Systemic administration of colony stimulating factors to treat amyloid associated disorders |
WO2024017998A1 (en) | 2022-07-21 | 2024-01-25 | Technische Universität Dresden | M-csf for use in the prophylaxis and/or treatment of viral infections in states of immunosuppression |
EP4309666A1 (en) | 2022-07-21 | 2024-01-24 | Technische Universität Dresden | M-csf for use in the prophylaxis and/or treatment of viral infections in states of immunosuppression |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4784949A (en) * | 1984-04-19 | 1988-11-15 | Cetus Corporation | Universal dominant selectable marker cassette |
US4847201A (en) * | 1985-02-05 | 1989-07-11 | Cetus Corporation | DNA encoding for CSF-1 and accompanying recombinant systems |
WO1986004607A1 (en) * | 1985-02-05 | 1986-08-14 | Cetus Corporation | Recombinant colony stimulating factor-1 |
WO1986004587A1 (en) * | 1985-02-05 | 1986-08-14 | Cetus Corporation | Purification of native colony stimulating factor-1 |
JP2583770B2 (ja) * | 1986-09-17 | 1997-02-19 | 大塚製薬株式会社 | 遺伝子 |
JP2644794B2 (ja) * | 1986-10-24 | 1997-08-25 | カイロン コーポレイション | 新規な型のコロニー刺激因子―1 |
-
1987
- 1987-04-13 AT AT87903104T patent/ATE92966T1/de not_active IP Right Cessation
- 1987-04-13 JP JP62502580A patent/JP2579981B2/ja not_active Expired - Fee Related
- 1987-04-13 MX MX9203130A patent/MX9203130A/es unknown
- 1987-04-13 WO PCT/US1987/000835 patent/WO1987006954A1/en active IP Right Grant
- 1987-04-13 EP EP87903104A patent/EP0307402B1/en not_active Expired - Lifetime
- 1987-04-13 HU HU872369A patent/HU212277B/hu not_active IP Right Cessation
- 1987-04-13 DE DE87903104T patent/DE3787020T2/de not_active Expired - Fee Related
- 1987-04-13 AU AU72890/87A patent/AU606056B2/en not_active Ceased
- 1987-04-15 IE IE99487A patent/IE60835B1/en not_active IP Right Cessation
- 1987-04-28 CA CA000535772A patent/CA1334942C/en not_active Expired - Fee Related
- 1987-05-01 IL IL82400A patent/IL82400A0/xx not_active IP Right Cessation
- 1987-05-04 GR GR870688A patent/GR870688B/el unknown
- 1987-05-04 MY MYPI87000572A patent/MY101209A/en unknown
- 1987-05-05 PH PH35225A patent/PH24301A/en unknown
- 1987-05-05 ES ES878701345A patent/ES2007341A6/es not_active Expired
-
1988
- 1988-01-05 NO NO880022A patent/NO880022L/no unknown
- 1988-01-05 DK DK002688A patent/DK2688A/da not_active Application Discontinuation
- 1988-01-06 KR KR88700005A patent/KR960004453B1/ko not_active IP Right Cessation
- 1988-10-21 FI FI884877A patent/FI884877A0/fi not_active Application Discontinuation
- 1988-11-04 OA OA59465A patent/OA09112A/xx unknown
-
1989
- 1989-08-14 US US07/393,435 patent/US5573763A/en not_active Expired - Lifetime
-
1994
- 1994-10-19 JP JP6253964A patent/JPH07147989A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH07147989A (ja) | 1995-06-13 |
DE3787020D1 (de) | 1993-09-16 |
EP0307402A4 (en) | 1990-02-22 |
FI884877A (fi) | 1988-10-21 |
IE870994L (en) | 1987-11-06 |
IE60835B1 (en) | 1994-08-24 |
DK2688D0 (da) | 1988-01-05 |
HU212277B (en) | 1996-04-29 |
JP2579981B2 (ja) | 1997-02-12 |
PH24301A (en) | 1990-05-29 |
MX9203130A (es) | 1992-07-01 |
GR870688B (en) | 1987-09-07 |
AU606056B2 (en) | 1991-01-31 |
FI884877A0 (fi) | 1988-10-21 |
NO880022D0 (no) | 1988-01-05 |
US5573763A (en) | 1996-11-12 |
MY101209A (en) | 1991-08-17 |
EP0307402A1 (en) | 1989-03-22 |
OA09112A (en) | 1991-10-31 |
DE3787020T2 (de) | 1993-12-16 |
ATE92966T1 (de) | 1993-08-15 |
DK2688A (da) | 1988-03-07 |
IL82400A0 (en) | 1987-11-30 |
EP0307402B1 (en) | 1993-08-11 |
KR880701288A (ko) | 1988-07-26 |
HUT47979A (en) | 1989-04-28 |
AU7289087A (en) | 1987-12-01 |
KR960004453B1 (en) | 1996-04-06 |
CA1334942C (en) | 1995-03-28 |
WO1987006954A1 (en) | 1987-11-19 |
ES2007341A6 (es) | 1989-06-16 |
JPH01502397A (ja) | 1989-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO880022L (no) | Fremstilling av m-csf. | |
NO161910C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetralinderivater. | |
NO162613C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive diarylacetylener. | |
NO874869D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
DK173883D0 (da) | Substituerede 8-phenylxanthiner | |
KR900701323A (ko) | 신규한 녹내장 치료용 안과 제제 | |
ATE69953T1 (de) | Verwendung von polysulfatierten heparinen. | |
AU624067B2 (en) | Preparation suitable for use in the treatment of enteric disorders | |
DK496687D0 (da) | Anvendelse af medetomidin til fremstilling af laegemiddel til brug ved behandling af angstsygdomme | |
EP0178443A3 (en) | Soaps and shampoos containing bioemulsifiers | |
NO162557C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner. | |
EP0241889A3 (de) | Verwendung von TNF zur Herstellung von Arzneimitteln | |
IT7967029A0 (it) | Amminoderivati della pirazolo i 5 as triazina particolarmente utili in terapia e procedimento per la loropreparazione | |
IT1133044B (it) | Procedimento per la riduzione della stabilita' termica del caglio microbico | |
IT1173473B (it) | Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni,in particolare per l'uso nel trattamento di psoriasi | |
NO164417C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater. | |
SE8404334L (sv) | 16-fluoro-16,17-didehydro-prostanoider och forfarande for deras framstellning | |
DE3764559D1 (de) | 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung. | |
ZA874470B (en) | New tetrahydrobenzothiazoles,and the preparation and use thereof | |
NO170922C (no) | Fremgangsmaate for fremstilling av hydrogenperoksyd | |
IT7967130A0 (it) | Rivati del 5 fenetil 2 ossazolidone ne e procedimento per la loro preparazione | |
NO170012C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider | |
PT85278A (fr) | Procede de preparation d:une fraction immunogene active a liegard des bilharzioses et de compositions immunisantes la contenant | |
TR24449A (tr) | Tiyazinol tuerevleri hazirlanmalarina mahsus usul v ve fungusid olarak kullanimi | |
ES545117A0 (es) | Procedimiento de preparacion de nuevos derivados de acido- 9- u 11-nitroaprovincaminico racemicos y opticamente activos |